Harvest Group Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Harvest Group Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-123	Closed	-$1K	–	816
2020 Q2	$1K	Hold	123	–	–	﹤0.01%	423
2020 Q1	$1K	Hold	123	–	–	﹤0.01%	437
2019 Q4	$1K	Hold	123	–	–	﹤0.01%	872
2019 Q3	$1K	Hold	123	–	–	﹤0.01%	928
2019 Q2	$1K	Hold	123	–	–	﹤0.01%	816
2019 Q1	$2K	Buy	+123	New	+$2.17K	﹤0.01%	681

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Harvest Group Wealth Management's TEVA Position: Q3 2020 in Review

Harvest Group Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2020, closing a stake of 123 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in TEVA in Q1 2019 and held it in 6 quarters. The position peaked at $2K in Q1 2019. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Harvest Group Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2020 after selling out during the quarter.
Harvest Group Wealth Management sold 123 Teva Pharmaceutical Industries Limited shares in Q3 2020, an estimated $1K.
Harvest Group Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2019 and held it in 6 quarters.
Harvest Group Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $2K in Q1 2019.
444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Harvest Group Wealth Management's 13F filing for Q3 2020, filed 9 Nov 2020.